What’s the difference between a “good” state for telemedicine and a “bad” one?
The American Telemedicine Association released two reports at its annual conference earlier this month in Los Angeles, a state-by state analysis of coverage and reimbursement policies for telemedicine services and another on physician practice standards and licensure in each state.
Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) – National Institute of General Medical Sciences (NIGMS) to develop its Ligo-miR microRNA assay platform. This award follows a previous $400k Phase I award and will create a comprehensive portfolio of Ligo-miR products designed to address broad swaths of the microRNA market.
The NIH is the premier biomedical research center for the world. Its 27 Institutes and Centers employ approximately 18,000 employees doing a vast array of jobs, all supporting efforts for a healthy nation. For information on the NIH mission, goals, and Institutes and Centers, visit NIH Overview
This position is located in the Transfer Technology Center (TTC) of the National Cancer Institute, National Institutes of Health. The candidate selected for this position serves as a member of one of the Technology Transfer Center Units with responsibility for advising on and performing the full range of services that facilitate the transfer of new technologies and research materials, particularly with the private sector, for further research or commercial development as appropriate. Works closely with industrial, academic and federal scientists in the development and execution of complex Cooperative Research and Development Agreements (CRADAs). Manages and monitors the processes for handling CRADAs and potential inventions and licenses. Originates Material Transfer Agreements (MTAs), Confidential Disclosure Agreements (CDAs), Clinical Trial Agreements (CTAs), and other agreements required by the organizations serviced. Advises scientists on the suitability of each agreement for desired research project. Collaborates with the NIH Office of Technology Transfer to ensure that the interests of the NCI are represented in all technology transfer matters. Advises researchers and administrators on matters involving both domestic and foreign patent rights, policies and procedures. Participates in the development and conduct of educational programs designed to train NCI intramural and extramural scientists and administrative staff about inventions, patents, licensing, trade secrets, copyrights, and research and development agreements. Provides advice and guidance in resolving intellectual property issues in a variety of grants and contract initiatives. For more information, please visit http://ttc.nci.nih.gov/
The Tech Council of Maryland (TCM), Maryland’s largest technology trade association, last night announced the winners of its 27th Annual Industry Awards. The celebration and ceremony, which took place at the Bethesda North Marriott Hotel & Conference Center, was attended by more than 700 technology and business leaders from around the state.
“The breadth of accomplishments of this year’s award recipients is impressive – from the innovations being developed here in Maryland to the leadership of executives and educators to foster inspired workplace and school environments,” said Phil Schiff, TCM’s CEO. “We are proud to honor this year’s winners, which underscore the quality and value of the state’s technology and life sciences communities, and the importance of their work around the world.”
Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax™ drug substance protein antigen. RiVax™ is a vaccine candidate being developed to protect against ricin exposure. Soligenix will transfer the manufacturing processes and analytics to Emergent to conduct process development work that could potentially lead to a future commercial manufacturing collaboration.
On April 30, 2015, KeyGene USA, celebrated the opening of its new R&D facilities co-located at the University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) in Rockville, Maryland. The R&D facilities include offices, molecular biology labs, a state-of-the-art greenhouse and access to modern growth chambers, tissue culture facilities and other resources. KeyGene USA is part of KeyGene, a leader in molecular breeding and translational agriculture with its headquarters in Wageningen, the Netherlands. KeyGene USA’s research programs will primarily be focused on crops of significance to the North and South American markets.
The angel investor market in 2014 had a slight correction in investment dollars and in the deal size. Total investments in 2014 were $24.1 billion, a decrease of 2.8% over 2013, according to the Center for Venture Research at the University of New Hampshire. A total of 73,400 entrepreneurial ventures received angel funding in 2014, an increase of 3.8% over 2013 investments. The number of active investors in 2014 was 316,600 individuals, an increase of 5.9% from 2013. The change in both total dollars and the number of investments resulted in a deal size for 2014 that was smaller than in 2013 (a decrease in deal size of 6.4% from 2013). These data indicate that angels were active investors in 2014 but at decreased valuations than in previous years, indicating a slight market correction in valuations. However, the $24.1 billion is a robust amount and is close to the market high of $26.0 billion that occurred in 2007.
Washington, D.C., mayor Muriel Bowser has named Matt Bailey the first director of technology innovation for the Office of the Chief Technology Officer.
The appointment is part of an effort to create innovative solutions to address the challenges that Washington, D.C., faces as a city, said Bowser in a release.
There seems to be something special about coworking spaces. As researchers who have, for years, studied how employees thrive, we were surprised to discover that people who belong to them report levels of thriving that approach an average of 6 on a 7-point scale. This is at least a point higher than the average for employees who do their jobs in regular offices, and something so unheard of that we had to look at the data again.
Forest City Enterprises and its partners on Friday will break ground on a $65.6 million, 165,000-square-foot building at 1812 Ashland Ave. that will be a hub for Johns Hopkins University’s efforts to commercialize research.
Construction is expected to be completed in August 2016.
